$Jaguar Health (JAGX.US)$ The license agreement is for the U...

$Jaguar Health (JAGX.US)$ The license agreement is for the U.S. market for Venture Life's FDA-approved prescription product, Gelclair. Gelclair is used for the treatment of oral mucositis, also called “chemo mouth.” 

“We are very happy to have executed the in-license agreement for Gelclair – and thus to have initiated Jaguar’s commercial footprint in our core focus area of cancer supportive care,” said Lisa Conte, Jaguar’s president and CEO